Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT04460092

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Baqiyatallah Medical Sciences University (from the registry)
Registry
  • NCT NCT04460092
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04460092. Randomized; no masking; primary purpose supportive care. Start 2020-05-25 (actual); primary completion 2020-06-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
5-mm 32-gauge Insulin needles in the first three days of Intervention
Intervention (Device)
8-mm 32-gauge Insulin needles in the first three days of Intervention
Intervention (Device)
5-mm 32-gauge Insulin needles in the last three days of Intervention
Intervention (Device)
8-mm 32-gauge Insulin needles in the last three days of Intervention
Lead sponsor
Baqiyatallah Medical Sciences University (class: other)

Record details

Record id
cardio:ct-nct04460092
Content hash
f8565d8cd2dec9cb040f6b4327bb6576e1232493c6b7f756adf62c880ed97c88